The Regis Healthcare Ltd (ASX: REG) share price is in focus after the company reported FY26 revenue up 16% to $1,350.6 million and underlying EBITDA up 10% to $138.0 million, both exceeding earlier guidance.
Image source: Getty Images
What did Regis Healthcare report?
- Revenue from services: $1,350.6 million, up 16% year-on-year
- Underlying EBITDA: $138.0 million, up 10%
- Statutory NPAT: $55.7 million, up 14%
- Net operating cash flow: $336.3 million, up 10%
- Final dividend: 9.40 cents per share (100% franked), full year up 13% to 18.40 cents per share
- Net cash position at 30 June 2026: $173.8 million
What else do investors need to know?
Regis achieved mature home average occupancy of 96%, with Camberwell and Oxley facilities successfully ramping up to 99% occupancy by year-end. FY26 also featured the completion and integration of two acquisitions adding 830 beds—Rockpool in Queensland and OC Health in Victoria—and the divestment of two regional homes in Far North Queensland, generating a one-off pre-tax gain of $25.4 million.
The company lifted average advertised room prices by 10% across 70% of its portfolio, aimed at boosting future Refundable Accommodation Deposit (RAD) inflows. New-aged care sector funding reforms, including the reintroduction of RAD retention and higher maximum RAD limits, are expected to provide longer-term cashflow and margin improvements.
What did Regis Healthcare management say?
Regis CEO and Managing Director Andrew Kinkade said:
The FY26 results reflect solid operational performance, underpinned by mature home occupancy at 96%, the ramp-up of Camberwell and Oxley homes, and net RAD cash inflow of $250 million. During the year, the Rockpool and OC Health acquisitions were completed and integrated, adding high-quality homes to the portfolio. Continued investment in people, quality and technology, has strengthened the organisation's position to meet the evolving needs of residents and clients.
What's next for Regis Healthcare?
Regis expects to benefit from favourable demographic trends, ongoing high occupancy, and sector funding reforms under the new Aged Care Act. The business will continue its growth strategy—with expansion through a greenfield development pipeline of around 1,300 beds and further acquisitions being evaluated.
Management says the phased repricing of RADs and recurring RAD retention earnings will help support sustainable earnings growth and provide added funding for capital renewal and shareholder returns. Regis is focused on operational excellence, delivering quality outcomes, and leveraging recent technology investments to improve resident experience and productivity.
Regis Healthcare share price snapshot
Over the past 12 months, Regis Healthcare shares have declined 24%, trailing the All Ordinaries Index (ASX: XAO), which is flat over the same period.
